A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada

BACKGROUND: The objective of this analysis is to explore potential impact on operating room (OR) efficiency and incidence of residual neuromuscular blockade (RNMB) with use of sugammadex (Bridion™, Merck & Co., Inc., Kenilworth, NJ USA) versus neostigmine for neuromuscular block reversal in Cana...

Descripción completa

Detalles Bibliográficos
Autores principales: Insinga, Ralph P., Joyal, Cédric, Goyette, Alexandra, Galarneau, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112647/
https://www.ncbi.nlm.nih.gov/pubmed/27852231
http://dx.doi.org/10.1186/s12871-016-0281-3